Table 3 Studies of mortality within 30 days after the surgical lung biopsy procedure

Utz et al., Eur Respir J 2001

IPF = 46

OLB 73%

No of biopsies not described

- 16.7% in total population

- 4/10 had AE-IPF before SLB

CTD-UIP = 14

VATS 27%

1986-1995

- All IPF

- Lower DLCO

- 21.7% in IPF

Lettieri et al., Chest 2005

IPF = 42

OLB (no?)

No of biopsies not described

- 4.8%

- Mechanical ventilation

Non-IPF = 41

VATS (no?)

1996-2002

(5/6%)

- Immunologic treatment

- No difference IPF vs non-IPF, VATS vs OLB

Tiitto et al., Chest 2005

IPF = 64

OLB n = 42

1

- OLB 5.3%

- OLB

CTD-UIP = 12

VATS n = 34

1973-2002

- VATS 0%

Park et al., Eur J Cardio-Thorac Surg 2007

IPF = 140

OLB n = 50

2-3

- 4%

- AE-IPF

NSIP = 46

VATS n = 150

1990-2003

(8%)

- DLCO < 50%

COP = 14

No ICU patients

Sigurdsson et al., Ann Thorac Surg 2009

UIP = 23

OLB n = 45

1: 70%

- 3%

- No data of different ILDs

OP = 17

VATS n = 28

2: 20%

(4%)

NSIP = 6

1986-2007

- No difference OLB vs VATS

Others = 27

Fibla et al., Int J Cardiovasc Thorac Surg 2012

IPF = 122

OLB 10%

1: 16%

VATS 9%

- Age > 67

COP = 31

VATS 90%

2: 64%

OLB 10.6%

- OLB

RBILD = 16

3: 59%

- Immunologic treatment

NSIP = 13

4: 1%

- No data of different ILDs

Others = 114

2002-2009

6% in ICU